« Previous
Next »
Titles
- Raising the bar: how California can use purchasing power and oversight to improve quality in Medi-Cal managed care1
- Rare diseases: Although limited, available evidence suggests medical and other costs can be substantial : report to congressional committees1
- Rare diseases: considerations for the development of drugs and biological products : guidance for industry1
- Rate regulation revisited: managing regulatory failure and regulatory capture in health care1
- Real-time oncology review (RTOR): guidance for industry1
- Real-world data: assessing registries to support regulatory decision-making for drug and biological products : guidance for industry1
- Recognizing destabilization in the individual health insurance market1
- Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry1
- Recommendations to reduce the risk of transfusion-transmitted malaria: guidance for industry1
- Reducing Medicare’s payment rates for intermittent urinary catheters can save the program and beneficiaries millions of dollars each year1
- Referencing the definition of “device” in the Federal Food, Drug, and Cosmetic Act in guidance, regulatory documents, communications, and other public documents: guidance for industry and Food and Drug Administration staff1
- Reformulating drug products that contain carbomers manufactured with benzene: guidance for industry1
- Refusal of inspection by a foreign food establishment or foreign government: guidance for industry1
- Regenerative medicine and advanced therapies: information on workforce and education : report to congressional committees1
- Regenerative medicine. Therapeutic applications, challenges, and policy options1
- Registration and listing of cosmetic product facilities and products: guidance for industry1
- Regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps): small entity compliance guide : guidance for industry1
- Regulatory requirements for hearing aid devices and personal sound amplification products: guidance for industry and Food and Drug Administration staff1
- Replacement reagent and instrument family policy for in vitro diagnostic devices: guidance for industry and Food and Drug Administration staff1
- Requirements for additional traceability records for certain foods: what you need to know about the FDA regulation : guidance for industry : small entity compliance guide1